Found 12 matching trials
Evaluating the Safety and Immune Response to Five Different Combinations of HIV Vaccines in Healthy, HIV-Uninfected Adults PHASE1 This study will evaluate the safety and immune response to five different c...
Show More Location
Multiple Locations
Learn More & Join Trial
Evaluating the Safety and Immune Response to Different Combinations of the DNA-HIV-PT123 and AIDSVAX® B/E Vaccines in Healthy, HIV-Uninfected Adults PHASE1 This study will evaluate the safety, tolerability, and immune response to d...
Show More Learn More & Join Trial
A Combination Efficacy Study in Africa of Two DNA-MVA-Env Protein or DNA-Env Protein HIV-1 Vaccine Regimens With PrEP PHASE2 This international, multi-centre, double-blind vaccine study is a three-arm...
Show More Location
MRC/UVRI and LSHTM Uganda Research Unit
Learn More & Join Trial
Evaluating the Safety and Immune Response to Three HIV Vaccine Schedules in Healthy, HIV-Uninfected Adults PHASE1 NOTE: This study has stopped enrolling new participants, and all study vacc...
Show More Learn More & Join Trial
Safety and Immune Response to a Clade C DNA HIV Vaccine PHASE1 The purpose of this study is to evaluate the safety and immune response to ...
Show More Location
Aurum Tembisa CRS
Learn More & Join Trial
Evaluating the Safety and Immunogenicity of HIV Clade C DNA Vaccine and MF59- or AS01B-Adjuvanted Clade C Env Protein Vaccines in Various Combinations in Healthy, HIV-Uninfected Adults PHASE1 This study will evaluate the safety and immune response to the DNA-HIV-PT12...
Show More Learn More & Join Trial
Evaluation of the Effect of Late Boost on HIV-uninfected Vaccines From EV06 Trial PHASE1 EV07 is an open label phase I clinical trial to evaluate the effect of late...
Show More Location
Uganda Virus Research Institute - International AIDS Vaccine Initiative HIV Vaccine Program (UVRI-IAVI)
Learn More & Join Trial
Safety and Immunogenicity Study of a DNA Vaccine Combined With Protein Vaccine Against HIV/AIDS PHASE1 The primary objective of the proposed phase I trial is to evaluate the safe...
Show More Location
Uganda Virus Research Institute - International AIDS Vaccine Initiative HIV Vaccine Program (UVRI-IAVI)
Learn More & Join Trial
Dose Escalation Trial of CD40.HIVRI.Env Vaccine Combined or Not With a DNA-HIV-PT123 HIV-1 Vaccine in Healthy Volunteers PHASE1 FIRST PART: DOSE ESCALATION Multicenter double-blind placebo controlled pha...
Show More Location
Hôpital Henri Mondor
Learn More & Join Trial
A Prophylactic HIV Vaccine Trial to Evaluate the Safety and Immunogenicity of HIV Clade C DREP Alone and in Combination With a Clade C ENV Protein in Healthy HIV-uninfected Adults PHASE1 EHVA P01 is an international, phase I, prophylactic HIV vaccine trial to ev...
Show More Learn More & Join Trial